Skip Navigation

Right arrow Return to article


TABLE 1 Effects of Neonatal Estradiol Valerate (EV) Exposure





Body


Testis


H/B EP


Tail EP


SV

Control (5) 435 ± 8 3.82 ± 0.05 0.68 ± 0.01 0.50 ± 0.01 1.49 ± 0.05
PD 1 (5) 424 ± 5 3.76 ± 0.08 0.74 ± 0.02 0.52 ± 0.01 1.51 ± 0.05
PD 1–3 (8) 434 ± 7 2.94 ± 0.15 0.59 ± 0.03 0.41 ± 0.02* 0.73 ± 0.11*
PD 1–6 (3) 429 ± 24 1.86 ± 0.13* 0.34 ± 0.04* 0.26 ± 0.01* 0.19 ± 0.06*
PD 4–6 (5) 407 ± 6 2.99 ± 0.06 0.58 ± 0.01 0.42 ± 0.01 1.11 ± 0.05*
PD 7–12 (3) 425 ± 9 2.81 ± 1.07 0.54 ± 0.06 0.34 ± 0.04* 1.11 ± 0.07
PD 13–18 (5) 468 ± 11 3.87 ± 0.04 0.72 ± 0.04 0.54 ± 0.01 1.84 ± 0.11*
PD 19–24 (5) 401 ± 5 3.78 ± 0.03 0.72 ± 0.01 0.49 ± 0.01 1.67 ± 0.04
PD 25–30 (5)

413 ± 9

3.32 ± 0.45

0.63 ± 0.08

0.42 ± 0.05

1.85 ± 0.09*

Note. Effect of neonatal estradiol valerate (EV) exposure for various postnatal days (PD) on body weight (g) and paired absolute weight (g) of the testis, head and body of the epididymis (H/B EP), tail of the epididymis (Tail EP), and seminal vesicle (SV) in rats at 117–137 days of age. Data are expressed as mean ± SEM.

* Significantly different from controls (p < 0.05). Relative weights showed essentially similar differences at (p < 0.05) and thus were not included.





Right arrow Return to article